All we're proposing to clinicians is Hey, think about the patients who are at risk and have a strategy to monitor and mitigate that risk. What about patients on GLP-1s
The medication's impact on blood sugar levels is evident in both fasting plasma glucose (FPG) reductions and improvements in postprandial glucose levels
Supplements can be layered thoughtfully, but only after the basics are stable
6 It is important to keep this in proportion: Group 2B is a hazard category, not a statement of real-world risk at typical intakes, the WHO's expert committee left the acceptable daily intake unchanged, and the FDA disagreed with the classification
Together, these ingredients are designed to support hormones, improve post-meal control, and create more stable metabolic conditions overall
This study looked at their body weight and various health parameters